Locations:
November 28, 2025/Cancer

Management of Pregnancy-Associated Breast Cancer (Podcast)

Supporting patients during pregnancy and beyond

Pregnancy-associated breast cancer is defined as breast cancer diagnosed during pregnancy and after one year after pregnancy. This represents
roughly one in 3,000 pregnancies.

In a recent episode of Cleveland Clinic's Cancer Advances podcast, Erin Roesch, MD, Breast Medical Oncologist discussed:

  • Supporting patients through diagnosis, therapy and recovery
  • How a multidisciplinary team approach helps optimize treatment timing, ensures maternal and fetal safety
  • Managing side effects during pregnancy and chemotherapy
  • Addressing breast feeding during and after treatment

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Click the podcast player above to listen to the episode now.

Podcast excerpt:

Podcast host Dr. Shepard: I'm guessing that managing the complexity of having a breast cancer, coupled with pregnancy, must take a big team. We're going to talk about multidisciplinary care. What does that look like?

Dr. Roesch: Multidisciplinary are includes multiple team members - medical oncologists, breast surgeons, radiation oncologists, genetic counselors, social workers, psychologists, obstetricians, gynecologists and sometimes reproductive providers.

Dr. Shepard: Are there things over time we've learned to do really well?
Where do we need to make improvements?

Dr. Roesch: In terms of some of the psychosocial aspects, we're striving to make improvements and gain a better understanding of the needs of this
population beyond chemotherapy, radiation, and surgery.

It's about having a better understanding of this patient population. Many of these patients may be interested in future pregnancies, so engaging
reproductive endocrinology early on to discuss oncogertility, providing
access to psychologists and social workers, so they're aware that they
have a full team of support. That's an area where continuous improvement
could be made.

And in terms of advances in cancer treatment, how do those advances impact
these patients, whether it's in the systemic therapy realm or in surgical
techniques. There's a lot of room to grow.

Advertisement

Related Articles

Dr. Dedousis
November 2, 2026/Cancer/Podcast

Expanding Germline Genetic Testing in Oncology (Podcast)

Are we missing patients?

Dr. Hanlee Chung
October 29, 2026/Cancer/Podcast

Redefining Resectability in Advanced Rectal Cancer (Podcast)

Expanding treatment options for patients with advanced and recurrent rectal cancer

Patient and healthcare providers
October 28, 2026/Cancer/Patient Support

Desire for Preventative Screening is Strong Among People Experiencing Homelessness

Study analyzes creative approaches to support people facing housing insecurity

AI tech
October 26, 2026/Cancer/Innovations

AI Task Force Develops Unified Strategy to Integrate Tech Innovations

Evaluating AI initiatives and their impact on operations and care delivery

DNA test
October 23, 2026/Cancer/News & Insight

Early Genetic Testing Linked to Bilateral Mastectomy in Young BRCA Carriers with Breast Cancer

Study reinforces the importance of genetic testing prior to local therapy decisions

Dr. Arun Singh
October 21, 2026/Cancer

Preserving Vision in Uveal Melanoma (Podcast)

Understanding expanding treatment options and potential advances

Patient and doctor
October 9, 2026/Cancer/News & Insight

First Radioligand Therapy Approved for Metastatic Hormone-Sensitive Prostate Cancer

Adding 177Lu-PSMA-617 to ADT plus an ARPI cut the risk of radiographic progression or mortality by 28%

Woman running
October 7, 2026/Cancer/Patient Support

Pilot Project Aids Cancer Survivors in Achieving Healthy Weight and Reducing Recurrent Risk

New program will help patients improve fitness and manage weight after cancer treatment

Ad